Statin exposure and thrombosis risk in patients with myeloproliferative neoplasms

被引：2
|
作者：
Delluc, Aurelien [1 ,2 ,6 ]
Lacut, Karine [1 ,3 ]
Pan-Petesch, Brigitte [1 ,4 ]
Galinat, Hubert [1 ,4 ]
Lippert, Eric [5 ]
Ianotto, Jean-Christophe [1 ,4 ]
机构：
[1] Brest Univ, EA GETBO 3878, F-29200 Brest, France
[2] Hop Cavale Blanche, Dept Chest Dis & Internal Med, F-29609 Brest, France
[3] Hop Cavale Blanche, INSERM CIC 1412, F-29609 Brest, France
[4] Hop Morvan, Oncol & Hematol Inst, F-29609 Brest, France
[5] Brest Univ, IBSAM, Genet Genom Fonct & Biotechnol UMR1078, Lab Hematol,Equipe ECLA, F-29200 Brest, France
[6] Ottawa Hosp, Ottawa Hosp Res Inst, Clin Epidemiol Program, Div Clin Hematol, Box 201B,501 Smyth Rd, Ottawa, ON K1H 8L6, Canada
来源：
THROMBOSIS RESEARCH | 2018年 / 167卷
关键词：
VENOUS THROMBOEMBOLISM; CANCER; COHORT;
D O I：
10.1016/j.thromres.2018.05.014
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：57 / 59
页数：3
相关论文
共 50 条
  • [1] Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms
    Zhao, Jie V.
    Schooling, C. Mary
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (04) : 267 - 268
  • [2] Risk for Arterial and Venous Thrombosis in Patients With Myeloproliferative Neoplasms RESPONSE
    Hultcrantz, Malin
    Bjorkholm, Magnus
    Landgren, Ola
    Kristinsson, Sigurdur Y.
    Andersson, Therese M. L.
    ANNALS OF INTERNAL MEDICINE, 2018, 169 (04) : 268 - 268
  • [3] Risk of thrombosis in patients with myeloproliferative neoplasms and elevated platelet counts
    Wahlin, Anders
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (01) : 5 - 6
  • [4] Antiphospholipid antibodies and the risk of thrombosis in myeloproliferative neoplasms
    Dambrauskiene, Ruta
    Gerbutavicius, Rolandas
    Rudzianskiene, Milda
    Paukstaitiene, Renata
    Vitkauskiene, Astra
    Skrodeniene, Erika
    Remeikiene, Diana
    Zaboriene, Inga
    Juozaityte, Elona
    OPEN LIFE SCIENCES, 2023, 18 (01):
  • [5] Risk for thrombosis in patients with myeloproliferative neoplasms was highest near the time of diagnosis
    Rabinowitz, Ian
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (10) : JC57 - JC57
  • [6] Hemorheologic disturbances as thrombosis risk factor in patients with some myeloproliferative neoplasms
    Roitman, E. V.
    Kolesnikova, I. M.
    Davydkin, I. L.
    Kozlova, N. S.
    Roumiantsev, S. A.
    THROMBOSIS RESEARCH, 2016, 140 : S198 - S198
  • [7] Shedding New Light on the Magnitude of Thrombosis Risk in Patients With Myeloproliferative Neoplasms
    Moliterno, Alison R.
    Ratchford, Elizabeth V.
    ANNALS OF INTERNAL MEDICINE, 2018, 168 (05) : 363 - +
  • [8] Thrombosis in Myeloproliferative Neoplasms
    Falanga, Anna
    Marchetti, Marina
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 2014, 40 (03): : 348 - 358
  • [9] Statin Use and the Risk of Myeloproliferative Neoplasms in a Population Based Cohort
    Kristensen, Daniel
    Oevlisen, Andreas K.
    Jakobsen, Lasse Hjort
    Severinsen, Marianne Tang
    El-Galaly, Tarec Christoffer Christoffer
    Roug, Anne Stidsholt
    BLOOD, 2022, 140 : 6813 - 6814
  • [10] Thrombosis in patients with myeloproliferative neoplasms. Case report
    Melikyan, Anait L.
    Subortseva, Irina N.
    Gilyazitdinova, Elena A.
    Koloshejnova, Tamara, I
    Shashkina, Kristina S.
    Egorova, Elena K.
    Kovrigina, Alla M.
    Sudarikov, Andrei B.
    Gorgidze, Lana A.
    TERAPEVTICHESKII ARKHIV, 2021, 93 (07) : 800 - 804
12345